openPR Logo
Press release

Premenstrual Syndrome Market Report Explored in Latest Research

01-06-2018 01:33 PM CET | Health & Medicine

Press release from: Transparency Market Research

Premenstrual Syndrome Market Report Explored in Latest

Premenstrual syndrome (PMS) alternatively known as premenstrual tension is a combination of physical, emotional, psychological disturbances among women of child bearing age. Premenstrual syndrome symptom occurs 1-2 weeks before the onset of menstruation and usually disappears once the menstrual bleeding starts. The exact cause of the disease is though not clear yet fluctuations in hormone level are one of the prominent reasons for onset of symptoms.

Other associated cause of the disease include low level of vitamin and mineral level, high intake of salty food and frequent alcohol & caffeine consumption. Symptoms of the diseases include acne, swollen breasts, troubled sleeping, muscles pain, mood swings and anxiety disorders. A more severe form of PMS known as premenstrual dysphoric disorder, characterized by repeated transitory cyclic disorder along with increased level of anger, anxiety and tension as compared to PMS disease.

Obtain Report Details @ https://www.transparencymarketresearch.com/premenstrual-syndrome-market.html

Approximately 20-30% of the menstruating women are believed to be affected by premenstrual syndrome of which 3-8% of them have premenstrual dysphoric disorder. Drugs that are usually employed as therapeutics include nonsteroidal anti-inflammatory drugs which control and regulate symptoms such as abdominal cramps, joint pain and headache. Antidepressants such as fluoxetine, paroxetine and sertraline can also be included in the regular therapy but it must be taken before actual symptoms begin. In premenstrual dysphoric disorder, gonadotropin-releasing hormone (GnRH) agonists such as leuprolide or goserelin can also be employed to regulate rapid fluctuations in the hormone levels.

Nutritional therapy such as vitamin B6, vitamin E, calcium and magnesium along with moderate exercise help in increasing success rate of treatment. Calcium carbonate can be recommended as first-line therapy for women with mild-to-moderate PMS whereas, selective serotonin reuptake inhibitors can be considered as first-line therapy for women with severe PMS complications.

Major drivers to the growth of premenstrual syndrome market includes increasing inclination of key players and government interventions towards developing novel therapeutics as a long term cure to this disease. Awareness and growing concern about premenstrual syndrome especially among women from developed economic countries have effectively contributed towards demand for PMS drugs and diagnostic tests. Till date there is no diagnostic device present to confirm PMS or PMDD yet two of the well-validated scales for the recording of premenstrual symptoms include the Calendar of Premenstrual Experiences (COPE) and the Prospective Record of the Severity of Menstruation (PRISM). Growing demand for hormone therapy based treatment across the globe has tremendously contributed towards increase in revenues and upliftment of PMS market.

Geographically, North America and Europe market are major contributors in terms of revenues and research activities. Availability of advanced diagnostic equipments and healthcare facilities has a major contribution towards growth and development of market in past few years. Rest of the World and Asia-Pacific market are among the most lucrative market for existing as well as new players in forthcoming years owing to large women population base and increasing incidences of lifestyle related disorders in past one decade.

Government interventions and campaigns with respect to women health and well-being are effectively contributing towards increasing awareness about Premenstrual syndrome and other associated menstrual disorders in developing economic countries. Some of the pipelined drugs in the market include ProgestoMat, Cis-platinum, CDB-2914, PH80-PMD, Dutasteride and others.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2922

Some of the key players operating in the Premenstrual Syndrome market include MetP Pharma AG, Umecrine Mood AB, DEKK-TEC, Inc., Pherin Pharmaceuticals, Inc. and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Premenstrual Syndrome Market Report Explored in Latest Research here

News-ID: 888315 • Views: 169

More Releases from Transparency Market Research

Craft Spirits Market Advancements, Evolving Industry Trends and Insights 2019 …
The domestic production of liquor, through the process of fermentation and distillation, encompassed the global craft spirits market. They are typically produced in a specified production volume, and the norm is below a standard of 750,000 gallons. Licensed distillers having independent operations with operational control from an alcoholic beverage vendor, and less than 25% capital investment, can produce craft spirits. The global craft spirits market, though at a nascent stage
Hemp Protein Market Popular Trends advancements to Watch Out for Near Future; Gl …
Hemp protein is a plant-based product, extracted from the seeds of the hemp plant, Cannabis sativa L., and is used in some protein supplements and protein-enriched foods. It is confused with the Hemp and marijuana plants which closely related; however, hemp generally refers to varieties that are grown for food and industrial uses. Hemp plants contains very low concentration of the chemicals that give marijuana its psychoactive and intoxicating properties.
Global Silicone Defoamer Market to Reap Excessive Revenues by 2025
Silicone defoamers are chemically inert in nature and act as antifoaming agents in a much effective manner than organic antifoam agents. With these properties, silicone defoamers are commonly used by a number of end use industries including food and beverages, textiles, and pharmaceuticals. This can be attributed to the defects that is caused to the surface coating as a result of foams. When used as cleaners, polish, and detergents, silicone
Iron Oxide Pigments Market to Garner Brimming Revenues by 2025
The players within the global iron oxide pigments market are concentrating their efforts on organic growth strategies. The last few years have seen a heightened demand for these pigments which has resulted in players looking to capitalize on this trend. Many companies are also looking for expansion of their manufacturing facilities. For instance Lanxess has encompassed its milling and mixing plant to its existing pigment plant in Ningbo, China. Get

All 5 Releases


More Releases for Premenstrual

Premenstrual Syndrome Global Market Research Report 2025
Premenstrual Syndrome Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/premenstrual-syndrome-market/80984 The report firstly introduced the Premenstrual Syndrome basics: definitions, classifications, applications and
Global Premenstrual Syndrome Medicine Market Production and Consumption Reports …
In this report, the global Premenstrual Syndrome Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Premenstrual Syndrome Medicine for these regions, from 2013 to
Premenstrual Syndrome Market : Overview with Detailed Analysis, Competitive land …
Premenstrual syndrome (PMS) alternatively known as premenstrual tension is a combination of physical, emotional, psychological disturbances among women of child bearing age. Premenstrual syndrome symptom occurs 1-2 weeks before the onset of menstruation and usually disappears once the menstrual bleeding starts. The exact cause of the disease is though not clear yet fluctuations in hormone level are one of the prominent reasons for onset of symptoms. View Report: https://www.transparencymarketresearch.com/premenstrual-syndrome-market.html Other associated cause
Premenstrual Syndrome - Pipeline Review, H2 2017
"The Report Premenstrual Syndrome - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Premenstrual Syndrome - Pipeline Review, H2 2017, provides an overview of the Premenstrual Syndrome (Women's Health) pipeline landscape. Premenstrual syndrome (PMS) is a collection of physical and emotional symptoms related to a woman's menstrual cycle. Premenstrual
Premenstrual Syndrome Market: Future Demand and Growth Analysis
Premenstrual syndrome (PMS) alternatively known as premenstrual tension is a combination of physical, emotional, psychological disturbances among women of child bearing age. Premenstrual syndrome symptom occurs 1-2 weeks before the onset of menstruation and usually disappears once the menstrual bleeding starts. The exact cause of the disease is though not clear yet fluctuations in hormone level are one of the prominent reasons for onset of symptoms. Other associated cause of
Premenstrual Dysphoric Disorder Market - Global Industry Analysis, Size, Share, …
ResearchMoz added Latest Research Report titled " Premenstrual Dysphoric Disorder Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020 " to it's Large Report database. Premenstrual dysphoric disorder (PMDD) is a severe condition in which most women develop depression, irritability and tension before menstruation. The U.S. Department of Health and Human Services stated that, premenstrual dysphoric disorder is more severe and serious compared to premenstrual syndrome